VRDN
Viridian Therapeutics, Inc.
$30.48−0.77 (−2.46%)Close Nov 12, 2026
Top holders
| Fund | %Weight (%) | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.7 | $72.1M |
| VTIVanguard Morningstar Total Stock Market ETF | 0.0 | $61.3M |
| IWMiShares Russell 2000 ETF | 0.1 | $43.1M |
| FSPHXFidelity Select Health Care Portfolio | 0.5 | $34.7M |
| FCTDXStrategic Advisers Fidelity U.S. Total Stock Fund | 0.0 | $32.3M |
| FBIOXFidelity Select Biotechnology Portfolio | 0.5 | $30.3M |
| PRHSXT. Rowe Price Health Sciences Fund | 0.2 | $26.6M |
| PRNHXT. Rowe Price New Horizons Fund | 0.2 | $24.8M |
| VXFVanguard Extended Market ETF | 0.0 | $20.8M |
| FSSNXFidelity Small Cap Index Fund | 0.1 | $18.7M |
Holders
- Funds
- 75
- Held in all
- $557M
- Held by the top 10
- 65.4%
- Highest weight
- SBIO1.3%